Sudden cardiac death in the young: A strategy for prevention by targeted evaluation

被引:64
作者
Sen-Chowdhry, Srijita
McKenna, William J.
机构
[1] UCL, Ctr Cardiol Young, Heart Hosp, London W1G 8PH, England
[2] Imperial Coll, Natl Heart & Lung Inst, London, England
关键词
arrhythmia; cardiomyopathy; genetics; sudden death;
D O I
10.1159/000091640
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The annual incidence of sudden cardiac death (SCD) in the general population is estimated as 1 in a 1,000. Since survival rates from out-of-hospital cardiac arrests are poor, primary prevention is key to reducing the burden of SCD in the community. Prominent causes of SCID include ischaemic heart disease, anomalous coronary arteries, and the primary myocardial diseases: hypertrophic cardiomyopathy, dilated cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy (ARVC). In 4% of sudden deaths in the 16-64 age group, postmortem examination fails to identify a cause, yielding a default diagnosis of sudden arrhythmic death syndrome (SADS). The inherited arrhythmia syndromes (long QT, short QT, and Brugada syndromes, and familial catecholaminergic polymorphic ventricular tachycardia) may be implicated in SAIDS, owing to their propensity for producing ventricular tachyarrhythmia in the structurally normal heart. Monogenic disorders therefore predominate as causes of SCID in the young. The advent of effective therapies for these diseases, particularly implantable cardioverter defibrillators, has prompted calls for universal screening to enable timely diagnosis of occult cardiac disease. Since prospective cardiac assessment of the general population is not feasible, the solution may be to target high-risk subgroups, namely, patients with cardiac symptoms, relatives of SCID victims, and competitive athletes. The recommended preliminary work-up includes a 12-lead ECG, signal-averaged ECG, transthoracic echocardiogram, exercise test, and ambulatory ECG monitoring. Cardiovascular magnetic resonance is a useful adjunct in patients with suspected ARVC or anomalous coronary arteries. Provocative challenge with a sodium challenge blocker may be of value in unmasking the Brugada syndrome. Identification of disease-causing mutations in affected individuals facilitates cascade screening of families. Copyright (c) 2006 S. Karger AG, Basel
引用
收藏
页码:196 / 206
页数:11
相关论文
共 65 条
  • [1] Genetic lipoprotein disorders and coronary atherosclerosis
    Alawadhi M.
    Thanassoulis G.
    Marcil M.
    Genest J.
    [J]. Current Atherosclerosis Reports, 2005, 7 (3) : 196 - 203
  • [2] Brugada syndrome - Report of the second consensus conference - Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association
    Antzelevitch, C
    Brugada, P
    Borggrefe, M
    Brugada, J
    Brugada, R
    Corrado, D
    Gussak, I
    LeMarec, H
    Nademanee, K
    Riera, ARP
    Shimizu, W
    Schulze-Bahr, E
    Tan, H
    Wilde, A
    [J]. CIRCULATION, 2005, 111 (05) : 659 - 670
  • [3] Late potentials and the Brugada syndrome
    Antzelevitch, C
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (12) : 1996 - 1999
  • [4] Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes
    Basso, C
    Maron, BJ
    Corrado, D
    Thiene, G
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (06) : 1493 - 1501
  • [5] Arrhythmogenic right ventricular cardiomyopathy - Dysplasia, dystrophy, or myocarditis?
    Basso, C
    Thiene, G
    Corrado, D
    Angelini, A
    Nava, A
    Valente, M
    [J]. CIRCULATION, 1996, 94 (05) : 983 - 991
  • [6] Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations
    Bauce, B
    Basso, C
    Rampazzo, A
    Beffagna, G
    Daliento, L
    Frigo, G
    Malacrida, S
    Settimo, L
    Danieli, G
    Thiene, G
    Nava, A
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (16) : 1666 - 1675
  • [7] Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome
    Behr, E
    Wood, DA
    Wright, M
    Syrris, P
    Sheppard, MN
    Casey, A
    Davies, MJ
    McKenna, W
    [J]. LANCET, 2003, 362 (9394) : 1457 - 1459
  • [8] Mutation in the KCNQ1 gene leading to the short QT-interval syndrome
    Bellocq, C
    van Ginneken, ACG
    Bezzina, CR
    Alders, M
    Escande, D
    Mannens, MMAM
    Baró, I
    Wilde, AAM
    [J]. CIRCULATION, 2004, 109 (20) : 2394 - 2397
  • [9] Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes
    Biffi, A
    Pelliccia, A
    Verdile, L
    Fernando, F
    Spataro, A
    Caselli, S
    Santini, M
    Maron, BJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (03) : 446 - 452
  • [10] Sudden, unexpected cardiac or unexplained death in England: a national survey
    Bowker, TJ
    Wood, DA
    Davies, MJ
    Sheppard, MN
    Cary, NRB
    Burton, JDK
    Chambers, DR
    Dawling, S
    Hobson, HL
    Pyke, SDM
    Riemersma, RA
    Thompson, SG
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2003, 96 (04) : 269 - 279